Azienda Ospedaliero-Universitaria di Modena

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.aou.mo.it

Clinical Trials

Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study

Completed

Conditions: Hypoparathyroidism
Parathyroid Diseases
Phosphorus and Calcium Disorders
Hyperparathyroidism

Interventions: Other: No intervention is provided

First Posted Date: 2018-11-20

Last Posted Date: 2021-02-09

Lead Sponsor: Azienda Ospedaliero-Universitaria di Modena

Target Recruit Count: 1038

Registration Number: NCT03747029

Locations: 🇮🇹
Azienda Ospedaliero - Universitaria di Modena, Modena, Italy

Colchicine for Amyotrophic Lateral Sclerosis

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: Colchicine 1 MG Oral Tablet
Drug: Placebo Oral Tablet

First Posted Date: 2018-10-03

Last Posted Date: 2023-03-01

Lead Sponsor: Azienda Ospedaliero-Universitaria di Modena

Target Recruit Count: 54

Registration Number: NCT03693781

Locations: 🇮🇹
Centro Sla, Ospedale Civile S. Agostino Estense, A.O.U. Modena, Modena, Italy
🇮🇹
Irccs Carlo Besta, Milano, Italy
🇮🇹
Centro Sla, University of Bari, Bari, Italy

and more 5 locations

Reliability of Serum Calcium to Phosphorus (Ca/P) Ratio as an Accurate and Inexpensive Tool to Define Disorders of Ca-P Metabolism

Completed

Conditions: Phosphorus and Calcium Disorders

Interventions: Other: No intervention are provided

First Posted Date: 2018-07-27

Last Posted Date: 2018-07-27

Lead Sponsor: Azienda Ospedaliero-Universitaria di Modena

Target Recruit Count: 606

Registration Number: NCT03603444

Locations: 🇮🇹
Azienda Ospedaliero - Universitaria di Modena, Modena, Italy

Development and Validation of a Self-assessment System Based on a Mobile App to Manage Adult Growth Hormone Deficiency

Not Applicable

Active, not recruiting

Conditions: Growth Hormone Deficiency

Interventions: Other: Use of "MAGHD App/MAGHD Framework"

First Posted Date: 2018-05-15

Last Posted Date: 2024-04-09

Lead Sponsor: Azienda Ospedaliero-Universitaria di Modena

Target Recruit Count: 83

Registration Number: NCT03525587

Locations: 🇮🇹
Azienda Ospedaliero - Universitaria di Modena, Modena, Italy

Rapamycin Treatment for ALS

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: Placebo Oral Tablet
Drug: Rapamycin

First Posted Date: 2017-12-02

Last Posted Date: 2022-08-11

Lead Sponsor: Azienda Ospedaliero-Universitaria di Modena

Target Recruit Count: 63

Registration Number: NCT03359538

Locations: 🇮🇹
Centro Clinico Nemo, Fondazione Serena Onlus, Milano, Milano, Italy
🇮🇹
Centro Sla, Irccs A.O.U. S.Martino Ist, Genova, Genova, Italy
🇮🇹
Centro Sla, Irccs Istituto Carlo Besta, Milano, Milano, Italy

and more 4 locations

Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer

Not Applicable

Recruiting

Conditions: Pancreatic Cancer

Interventions: Radiation: LDR
Drug: Gem-based doublets
Radiation: SBRT

First Posted Date: 2015-04-15

Last Posted Date: 2022-12-12

Lead Sponsor: Azienda Ospedaliero-Universitaria di Modena

Target Recruit Count: 44

Registration Number: NCT02416609

Locations: 🇮🇹
Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, MO, Italy

Different Fluidic Strategy in Patients With Acute Abdomen : The Sure Volume

Phase 2

Completed

Conditions: Acute Abdomen

Interventions: Other: Standard fluidic resuscitation.
Other: Volemic small treatment

First Posted Date: 2013-07-30

Last Posted Date: 2013-07-30

Lead Sponsor: Azienda Ospedaliero-Universitaria di Modena

Target Recruit Count: 99

Registration Number: NCT01911702

Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision

Not Applicable

Completed

Conditions: Goiter
Thyroid Neoplasms
Parathyroid Pathologies

Interventions: Device: Octylcyanoacrylate (Dermabond)
Device: Subcuticular reabsorbable suture (Caprosyn)

First Posted Date: 2008-09-17

Last Posted Date: 2010-05-05

Lead Sponsor: Azienda Ospedaliero-Universitaria di Modena

Target Recruit Count: 100

Registration Number: NCT00754182

Locations: 🇮🇹
Policlinico di Modena, Modena, Italy

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

Phase 3

Conditions: Breast Cancer

First Posted Date: 2008-03-05

Last Posted Date: 2013-08-07

Lead Sponsor: Azienda Ospedaliero-Universitaria di Modena

Target Recruit Count: 2500

Registration Number: NCT00629278

Locations: 🇮🇹
Ospedal San Andrea, Vercelli, Italy
🇮🇹
Ospedale Civile di Ivrea, Ivrea, Italy
🇮🇹
Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino, Turin, Italy

and more 3 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy